A randomized, controlled, double-blind, cross-over study of the effect of oral rabeprazole 20mg and intravenous pantoprazole 40mg on intragastric pH in patients

Trial Profile

A randomized, controlled, double-blind, cross-over study of the effect of oral rabeprazole 20mg and intravenous pantoprazole 40mg on intragastric pH in patients

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Apr 2010

At a glance

  • Drugs Pantoprazole; Rabeprazole
  • Indications Gastro-oesophageal reflux
  • Focus Pharmacodynamics
  • Sponsors Janssen Inc
  • Most Recent Events

    • 10 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top